Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial (Q32055417)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q92104162)
(Q110920550)
(P304) 69-77; discussion 77-9
(P433) 1
(P478) 187
(P577) Wednesday, July 1, 1998
(P921) (Q42824827)
(Q6934595)
(Q1427096)
(P1433) (Q15723630)
(P1476) "Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial" (language: en)
(P2093) Wallack MK
Sivanandham M
Urist MM
Bland KI
Murray D
Flaherty L
Richards JM
Bartolucci AA
Rosen L
(P2860) (Q34371245)
(Q35898621)
(Q34550480)
(Q36356458)
(Q72918261)
(Q40840772)
(Q67753693)
(Q38260536)
(Q41359422)
(Q68093669)
(Q69463580)
(Q53378993)
(Q36882492)
(Q45814892)
(Q45793855)
(Q70077640)
(Q24319940)
(Q51031002)
(Q24561706)
(Q24680097)
(Q24312048)
(Q28296086)
(Q68099227)
(Q68865814)
(Q46339324)
(Q34029001)
other details
description scientific article

External Links